Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

MERIDIAN BIOSCIENCE INC (VIVO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 11.3% stake in Meridian Bioscience Inc.
02/09/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/06/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/06/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/06/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/03/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
02/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
02/01/2023 8-K Quarterly results
01/31/2023 4 Williams Felicia (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 10,274 shares @ $0
Disposed/sold 12,000 options to buy @ $15.15, valued at $181.8k
Disposed/sold 8,740 options to buy @ $16.97, valued at $148.3k
Disposed/sold 17,205 options to buy @ $10.46, valued at $180k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 Sazdanoff Catherine (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 16,424 shares @ $0
Disposed/sold 8,500 options to buy @ $18.18, valued at $154.5k
Disposed/sold 8,500 options to buy @ $18.64, valued at $158.4k
Disposed/sold 12,000 options to buy @ $12.8, valued at $153.6k
Disposed/sold 12,000 options to buy @ $16.2, valued at $194.4k
Disposed/sold 8,740 options to buy @ $16.97, valued at $148.3k
Disposed/sold 17,205 options to buy @ $10.46, valued at $180k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 Rice John McCune Jr. (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 27,449 shares @ $0
Disposed/sold 12,000 options to buy @ $16.2, valued at $194.4k
Disposed/sold 8,740 options to buy @ $16.97, valued at $148.3k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 McIlwraith John (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 21,724 shares @ $0
Disposed/sold 8,500 options to buy @ $18.18, valued at $154.5k
Disposed/sold 8,500 options to buy @ $18.64, valued at $158.4k
Disposed/sold 10,000 options to buy @ $12.8, valued at $128k
Disposed/sold 12,000 options to buy @ $16.2, valued at $194.4k
Disposed/sold 8,740 options to buy @ $16.97, valued at $148.3k
Disposed/sold 17,205 options to buy @ $10.46, valued at $180k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 Ellingwood Dwight E (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 17,290 shares @ $0
Disposed/sold 8,500 options to buy @ $20.8, valued at $176.8k
Disposed/sold 5,500 options to buy @ $17.34, valued at $95.4k
Disposed/sold 8,500 options to buy @ $18.64, valued at $158.4k
Disposed/sold 11,000 options to buy @ $12.8, valued at $140.8k
Disposed/sold 12,000 options to buy @ $16.2, valued at $194.4k
Disposed/sold 8,740 options to buy @ $16.97, valued at $148.3k
Disposed/sold 17,205 options to buy @ $10.46, valued at $180k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 Bihl Anthony P III (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 15,408 shares @ $0
Disposed/sold 4,595 options to buy @ $23.5, valued at $108k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 Anderson James M. (Director) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Disposed/sold 28,224 shares @ $0
Disposed/sold 5,000 shares @ $0
Disposed/sold 8,500 options to buy @ $25.83, valued at $219.6k
Disposed/sold 8,500 options to buy @ $17.34, valued at $147.4k
Disposed/sold 8,500 options to buy @ $18.64, valued at $158.4k
Disposed/sold 12,000 options to buy @ $12.8, valued at $153.6k
Disposed/sold 12,000 options to buy @ $16.2, valued at $194.4k
Disposed/sold 8,740 options to buy @ $16.97, valued at $148.3k
Disposed/sold 17,205 options to buy @ $10.46, valued at $180k
Disposed/sold 5,796 options to buy @ $21.36, valued at $123.8k
Disposed/sold 5,656 options to buy @ $20.75, valued at $117.4k
01/31/2023 4 Kenny John P. (CEO) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Granted 47,060 shares @ $0
Disposed/sold 267,651 shares @ $0
Disposed/sold 66,039 options to buy @ $10.1, valued at $667k
Disposed/sold 83,535 options to buy @ $18.48, valued at $1.5M
Disposed/sold 82,940 options to buy @ $18.88, valued at $1.6M
01/31/2023 4 Kitzmiller Andrew S. (Executive Vice President & CFO) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Granted 7,945 shares @ $0
Disposed/sold 19,473 shares @ $0
Disposed/sold 5,000 options to buy @ $24.74, valued at $123.7k
01/31/2023 4 WELTZIEN LOURDES (Executive VP, Life Science) has filed a Form 4 on MERIDIAN BIOSCIENCE INC
Txns: Granted 7,945 shares @ $0
Disposed/sold 86,045 shares @ $0
Disposed/sold 10,000 options to buy @ $19.66, valued at $196.6k
Disposed/sold 2,500 options to buy @ $14.3, valued at $35.8k
Disposed/sold 12,107 options to buy @ $18.48, valued at $223.7k
Disposed/sold 11,669 options to buy @ $18.88, valued at $220.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy